ABUS Operating Expenses

Arbutus Biopharma Corp · Operating Expenses

ABUS logo

ABUS Operating Expenses

Latest reported$34.47M
ABUS TTM Operating Expenses ($3.20M → $34.47M)
High-resolution chart · PNG

ABUS operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Arbutus Biopharma Corp Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
34,471,000
36,744,000
54,209,000
52,222,000
66,190,000
80,248,000
73,680,000
72,311,000
75,748,000
75,475,000
78,680,000
79,210,000
76,757,000
82,071,000
81,526,000
80,458,000
78,443,000
55,265,000
35,717,000
33,221,999
16,148,999
15,166,999
15,381,999
15,322,000
32,134,000
49,378,000
64,789,000
80,048,000
78,255,000
77,530,000
76,117,000
80,608,000
80,703,000
80,518,000
80,832,000
81,068,000
81,028,000
99,737,000
101,783,000
102,989,000
107,453,000
85,720,000
78,533,000
70,203,000
57,196,000
50,930,000
47,925,000
42,818,761
38,217,083
32,772,805
27,572,926
-8,421,401
-13,278,873
-16,482,998
-19,603,997
8,647,485
8,309,116
7,615,801
7,380,379
-3,127,823
2,445,789
2,122,155
1,749,105
11,655,185
6,012,511
5,784,601
5,488,159
-7,987,049
-2,692,848
3,568,153
3,198,331
19,219,426
16,688,553
11,702,831
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.